1h Free Analyst Time
The NGS-Based RNA-Sequencing Market grew from USD 2.32 billion in 2023 to USD 2.67 billion in 2024. It is expected to continue growing at a CAGR of 17.32%, reaching USD 7.12 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Next-Generation Sequencing (NGS)-Based RNA-Sequencing is at the forefront of molecular biology, offering comprehensive access to transcriptome data with unprecedented depth and precision. This technology enables the mapping and quantification of RNA transcripts, aiding in understanding gene expression patterns, mutations, and their functional roles. The necessity for NGS-based RNA-Sequencing is underscored by its critical applications in personalized medicine, biomarker discovery, and drug development, with significant end-use in academic and clinical research, biotechnology, and pharmaceuticals. Key growth drivers include the rising demand for better diagnostic tools, the increasing prevalence of genetic disorders, and advancements in computational biology that facilitate complex data analysis. The integration of AI and machine learning into NGS analysis presents fresh opportunities, allowing for more accurate interpretations of genomic data which can enhance patient care and streamline drug discovery processes. New possibilities are emerging in targeted therapeutics and companion diagnostics, offering precision and efficiency. However, market growth faces limitations such as high initial setup costs, the need for skilled personnel, and ethical concerns regarding genetic data privacy. Data storage and management also pose significant challenges given the vast amount of information generated by NGS. Nevertheless, innovation areas like single-cell sequencing and multi-omics are ripe for exploration, promising enhanced sensitivity and specificity in genetic research. Moreover, improved methodologies to lower costs and address ethical issues are crucial for widening market adoption. As the market evolves, businesses tapping into automation and cloud-based solutions for data analysis can gain competitive advantages. Continuous collaboration between technology developers, healthcare providers, and regulatory bodies will be essential to overcome challenges and maximize the utility of NGS-based RNA-sequencing, thus driving sustained growth and widespread application across various sectors.
Understanding Market Dynamics in the NGS-Based RNA-Sequencing Market
The NGS-Based RNA-Sequencing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Surge in the adoption of next-generation sequencing
- Robust growth of precision medicines and rising amount of RNA sequencing grants
- Increasing demand for advanced sequencing-based diagnostics
- Market Restraints
- Cost of NGS instruments is high
- Market Opportunities
- Technological advancement in the RNA-Sequencing
- Increasing research activities related to RNA-Sequencing
- Market Challenges
- Unavailability of skilled manpower
Exploring Porter’s Five Forces for the NGS-Based RNA-Sequencing Market
Porter’s Five Forces framework further strengthens the insights of the NGS-Based RNA-Sequencing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the NGS-Based RNA-Sequencing Market
External macro-environmental factors deeply influence the performance of the NGS-Based RNA-Sequencing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the NGS-Based RNA-Sequencing Market
The NGS-Based RNA-Sequencing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the NGS-Based RNA-Sequencing Market
The NGS-Based RNA-Sequencing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the NGS-Based RNA-Sequencing Market
The NGS-Based RNA-Sequencing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the NGS-Based RNA-Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Becton, Dickinson and Company, BGI Group, Eurofins Scientific, F. Hoffmann-la Roche AG, Genewiz by Brooks Automation, Inc., Hamilton Company, Illumina, Inc., Merck KGaA, Oxford Nanopore Technologies, PerkinElmer, Inc., Psomagen, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific.Market Segmentation & Coverage
This research report categorizes the NGS-Based RNA-Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product & Services
- Data Analysis
- RNA Sequencing Platforms & Consumables
- RNA Sequencing Services
- Sample Preparation Products
- Storage & Management
- Technology
- Ion Semiconductor Sequencing
- Nanopore Sequencing
- Sequencing By Synthesis
- Single-Molecule Real-Time Sequencing
- Application
- De Novo Transcriptome Assembly
- Expression Profiling Analysis
- Small RNA Sequencing
- Variant Calling & Transcriptome Epigenetics
- End-User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Research & Academia
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. NGS-Based RNA-Sequencing Market, by Product & Services
7. NGS-Based RNA-Sequencing Market, by Technology
8. NGS-Based RNA-Sequencing Market, by Application
9. NGS-Based RNA-Sequencing Market, by End-User
10. Americas NGS-Based RNA-Sequencing Market
11. Asia-Pacific NGS-Based RNA-Sequencing Market
12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market
13. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the NGS-Based RNA-Sequencing Market, which are profiled in this report, include:- Agilent Technologies
- Becton, Dickinson and Company
- BGI Group
- Eurofins Scientific
- F. Hoffmann-la Roche AG
- Genewiz by Brooks Automation, Inc.
- Hamilton Company
- Illumina, Inc.
- Merck KGaA
- Oxford Nanopore Technologies
- PerkinElmer, Inc.
- Psomagen
- Qiagen N.V.
- Takara Bio Inc.
- Thermo Fisher Scientific
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 183 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 2.67 Billion |
| Forecasted Market Value ( USD | $ 7.12 Billion |
| Compound Annual Growth Rate | 17.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
